Navigating Market Uncertainty with Defensive Dividend Plays

Current market conditions present challenges, marked by stock wobbles and diminished expectations for interest rate cuts this year. Geopolitical tensions, particularly in the Middle East, have introduced significant risk factors for investors.

However, long-term trends suggest that Artificial Intelligence (AI) adoption will eventually temper wage growth, helping control inflation and potentially boosting corporate profits and dividends. This environment favors focusing on “Dividend Magnet” stocks—companies rapidly increasing their payouts.

Recent Middle East hostilities have caused pullbacks in many of these strong dividend growers, presenting a timely entry point. The following two examples are insulated from geopolitical events and are emerging as unexpected beneficiaries of the AI revolution.

Waste Management (WM): Trash Collection as a Stealth AI Play

Waste Management operates a business largely untouched by international conflicts, focusing quietly on essential waste collection services. As of year-end 2025 projections, the company's infrastructure includes 257 landfills, 482 transfer stations, 162 recycling depots, and 17 medical-waste incinerators.

This consistent operation has fueled impressive dividend growth. Investors who purchased shares a decade ago would currently realize a yield on cost approaching 6.6%. Furthermore, despite these rapid payout hikes, WM’s payout ratio has steadily declined over recent years.

AI Integration Driving Efficiency at WM

CEO Jim Fish recently indicated expectations for free cash flow (FCF) to increase by 30% this year, partly due to strategic AI investments. Management has committed $1.4 billion between 2022 and 2026 for automation initiatives.

These investments include deploying robotics enhanced by machine learning and advanced imaging. These robots can identify and sort up to 1,000 items per hour from the waste stream, significantly exceeding human sorting speeds.

While WM stock typically trades at a premium and has gained 3% this year, it has recently dipped 6% following the outbreak of Middle East hostilities. This pullback offers a solid entry opportunity for this top-tier dividend grower.

Gilead Sciences (GILD): Biotech Leveraging AI for Pipeline De-Risking

Gilead Sciences offers similar insulation from Middle East events, but its connection to AI integration is arguably even more pronounced within the pharmaceutical sector. AI is accelerating drug discovery by allowing companies to simulate new treatments computationally, reducing the need for costly, late-stage clinical failures.

This shift favors drugmakers with robust pipelines. Gilead, which focuses on oncology and HIV treatments that generate predictable revenue, currently has 25 treatments in Phase 1, 13 in Phase 2, and 15 in Phase 3 trials.

Gilead’s Dividend Momentum and Valuation

Gilead spent $5.7 billion, nearly 20% of its revenue, on Research & Development last year. AI integration, supported by its new 180,000-square-foot AI-enabled research center in California, is expected to further de-risk this substantial R&D spend.

The current dividend yield stands around 2.7%, which appears modest initially. However, the stock’s dividend growth has recently accelerated, evidenced by the latest increase being $0.03, up from the usual $0.02 hike—a 50% increase.

In the last quarter, Gilead’s FCF jumped 10% to $3.1 billion, easily covering the $1 billion paid out in dividends. Despite this positive momentum, GILD trades at a reasonable forward earnings multiple of 15.7 times, suggesting the market has not yet fully recognized its AI-driven potential.